Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Sharma

Showing results (441-450 of 464) with videos related to

Pageof 47
Sort By:
The New England Journal of Medicine|April 18, 2020
ST-Segment Elevation in Patients with Covid-19 - A Case SeriesSripal Bangalore, Atul Sharma, Alexander Slotwiner, et al.
Hematological Oncology|June 1, 2022
Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemiaSarita Kumari, M Shadab Ali, Jay Singh, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2015
Indian Council of Medical Research consensus document for the management of gall bladder cancerHari Shankar Shukla, Bhawna Sirohi, Anu Behari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2024
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled TrialAkhil Santhosh, Atul Sharma, Sameer Bakhshi, et al.
Leukemia & Lymphoma|November 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcomeLalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Meeting Proceedings of the 2nd Annual Immuno-Oncology Society of India Conference (I-OSICON-2020), Mumbai, IndiaJyoti Bajpai, Sujay Srinivas, George Abraham, et al.
Frontiers in Pharmacology|March 9, 2026
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH studyHemavathi Baskarane, Mohit Kumar Divakar, Akhil P Santhosh, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2023
Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational ProfileSurabhi Jain, Ansh Goswami, Moien R Lone, et al.
Cancer Communications (London, England)|July 6, 2022
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapyAjaz A Bhat, Sabah Nisar, Mayank Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2019
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trialAtul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, et al.
Pageof 47

Showing results (441-450 of 464) with videos related to

Sort By:
Pageof 47
The New England Journal of Medicine|April 18, 2020
ST-Segment Elevation in Patients with Covid-19 - A Case SeriesSripal Bangalore, Atul Sharma, Alexander Slotwiner, et al.
Hematological Oncology|June 1, 2022
Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemiaSarita Kumari, M Shadab Ali, Jay Singh, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2015
Indian Council of Medical Research consensus document for the management of gall bladder cancerHari Shankar Shukla, Bhawna Sirohi, Anu Behari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2024
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled TrialAkhil Santhosh, Atul Sharma, Sameer Bakhshi, et al.
Leukemia & Lymphoma|November 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcomeLalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Meeting Proceedings of the 2nd Annual Immuno-Oncology Society of India Conference (I-OSICON-2020), Mumbai, IndiaJyoti Bajpai, Sujay Srinivas, George Abraham, et al.
Frontiers in Pharmacology|March 9, 2026
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH studyHemavathi Baskarane, Mohit Kumar Divakar, Akhil P Santhosh, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2023
Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational ProfileSurabhi Jain, Ansh Goswami, Moien R Lone, et al.
Cancer Communications (London, England)|July 6, 2022
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapyAjaz A Bhat, Sabah Nisar, Mayank Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2019
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trialAtul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, et al.
Pageof 47